To evaluate the efficacy and safety of Chinese medicine ( CM ) intervention in the treatment of nonalcoholic steatohepatitis ( NASH ) from liver enzyme ( ALT ) , imaging ( the liver/spleen CT ratio ) and syndrome scores , and to establish standard methods for diagnosis and therapeutic efficacy evaluation with characteristics of CM .